Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

RxSight (RXST) Asset Utilization Ratio (2021 - 2026)

RxSight posted quarterly Asset Utilization Ratio of 0.41 for Q1 2026, down 11.84% year-on-year from 0.47 in Q1 2025, and down 4.51% on a QoQ basis from 0.43 in Q4 2025.

RxSight (RXST) has 6 years of Asset Utilization Ratio data on file, last reported at 0.41 in Q1 2026.

  • For the quarter ending Q1 2026, Asset Utilization Ratio fell 11.84% year-over-year to 0.41; the trailing twelve-month figure through Mar 2026 stood at 0.41 (down 11.84% YoY), and the FY2025 full-year result was 0.43, down 23.6% from the prior year.
  • Asset Utilization Ratio for Q1 2026 stood at 0.41, down from 0.43 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.55 in Q1 2024 and bottomed at 0.15 in Q1 2022.
  • The 5-year median for Asset Utilization Ratio is 0.42 (2024), against an average of 0.39.
  • The widest annual swing landed in 2022, when Asset Utilization Ratio soared 706.48%; it then dropped 15.06% in 2025.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.32 in 2022, then surged by 52.58% to 0.49 in 2023, then fell by 9.0% to 0.44 in 2024, then declined by 2.55% to 0.43 in 2025, then fell by 4.51% to 0.41 in 2026.
  • The last three Asset Utilization Ratio figures came in at 0.41 (Q1 2026), 0.43 (Q4 2025), and 0.46 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 0.46
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 0.54
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 0.39
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 0.47
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 0.47
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 0.65
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 0.74
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 0.57
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 0.56
10 RxSight 215.82 Mn -2.06 Mn 23.50 Mn 0.41

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 0.41
Dec 31, 2025 0.43
Sep 30, 2025 0.46
Jun 30, 2025 0.47
Mar 31, 2025 0.47
Dec 31, 2024 0.44
Sep 30, 2024 0.42
Jun 30, 2024 0.47
Mar 31, 2024 0.55
Dec 31, 2023 0.49
Sep 30, 2023 0.41
Jun 30, 2023 0.34
Mar 31, 2023 0.33
Dec 31, 2022 0.32
Sep 30, 2022 0.26
Jun 30, 2022 0.20
Mar 31, 2022 0.15
Dec 31, 2021 0.11
Sep 30, 2021 0.03